期刊文献+

良性前列腺增生症与血糖和血脂等代谢性指标的相关性 被引量:4

The correlation bwteen benign prostatic hyperplasia and blood fat sugar,blood and other metabolic index
下载PDF
导出
摘要 目的:探讨老年良性前列腺增生症(BPH)患者与血糖、血脂等代谢性指标的临床相关性。方法:收集92例BPH患者的临床资料,采用国际前列腺症状评分表(IPSS)对患者进行评价,所有患者均详细询问病史,并检测空腹血糖(FBG)、血脂系列、前列腺特异性抗原(PSA)水平,采用腹部超声测量前列腺体积(PV)。结果:老年BPH患者PV和PSA随年龄增加而增高;PV与FPG、血清PSA水平呈正相关;与高密度脂蛋白胆固醇(HDL-C)呈负相关;与总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)无相关性。结论:FBG,HDL-C为BPH患者病情进展的独立危险因素,TC、三酰甘油(TG)、LDL-C为前列腺增生的相关危险因素,与BPH之间存在密切关系。 Objective:To explore the clinical correlation between old benign prostatic hyperplasia disease(BPH)and blood sugar,blood fat and other metabolic index.Methods:The clinical datas of 92 elderly BPH cases was collected.To evaluate patients using international prostate symptoms scale(IPSS),all patients were asked in detail about the history,and testing standard fasting blood sugar(FBG),blood fat series,prostate specific antigen(PSA) levels.The prostate volume(PV) was measured by the abdominal ultrasound.Results:The elderly BPH paitens was elder,the PV and PSA of them was higher.The PV,serum PSA level with FBG positively correlated,And high density lipoprotein cholesterol(HDL-C) was negatively correlated,And total cholesterol(TC),low density lipoprotein cholesterol(LDL-C) was unrelated.Conclusion:FBG,HDL-C for patients with BPH was independent risk factors for the disease progression,TC,triglyceride(TG) and LDL-C for the related risk factors for prostate hyperplasia,there is a closely relationship with BPH.
作者 史丽英 司毅
出处 《临床医药实践》 2012年第5期338-339,共2页 Proceeding of Clinical Medicine
关键词 良性前列腺增生症 空腹血糖 血脂 benign prostatic hyperplasia disease fasting blood sugar blood fat
  • 相关文献

参考文献4

二级参考文献10

共引文献46

同被引文献27

  • 1王毅,邵继春,张蜀武.雄激素致去势大鼠前列腺增生的组织形态学研究[J].中华男科学杂志,2002,8(3):190-193. 被引量:10
  • 2张辉,王玉秋,袁晓东,丁森泰,李子尧,吕家驹.代谢综合征诊断指标与前列腺特异性抗原相关性研究[J].中华临床医师杂志(电子版),2011,5(21):6285-6290. 被引量:6
  • 3李培军,张祥华,郭利君,那彦群.高脂血症与良性前列腺增生相关性的临床研究[J].中华外科杂志,2005,43(6):387-389. 被引量:33
  • 4Lees S,Min HG,Choi SH,et al. Central obesity as a risk factor for prostatic hyperplasia[J]. Obesity ,2006,14 : 172-179.
  • 5Lekili M,Muezzinoglu T,Uyanik BS,et al. Serum lipid levels in be- nign prostatic hyperplasia[J]. World J Urol, 2006,24 : 210-213.
  • 6Hammarsten JB,Hogsted T,Hohhuis N,et al. Components of the metabolic syndrome risk factors for the development of benign pro- static hyperplasia[J]. Prostate Cancer and Prostatic Diseases, 1998, 1: 157-162.
  • 7Michel MC,Mehlburger L,Schumacher H,et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic, hyper- plasia[J]. J Urol ,2000,163 : 1725-1729.
  • 8Takata H, Fujimoto S. Metabolic syndrome [J].Nihon. Rinsho, 2013,71(2) :266-269.
  • 9Bradshaw PT, Monda KL, Stevens J. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the atherosclerosis risk in communities study[J]. Obesity (Silver Spring) ,2013,21(1) :203-209.
  • 10Esposito K,Chiodini P,Capuano A, et al. Effect of metabolic syn drome and its components on prostate Cancer risk..meta-analysis[J]. J Endocrinol Invest,2013,36(2):132- 139.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部